Results 131 to 140 of about 22,527 (249)

Continuous Infusion Versus Bolus Injection of Loop Diuretics for Patients With Congestive Heart Failure: A Meta-Analysis. [PDF]

Cureus, 2023
Karedath J, Asif A, Tentu N, Zahra T, Batool S, Sathish M, Sandhu QI, Khan A.   +7 more
europepmc   +1 more source

Diuretic resistance and the efficacy of hydrochlorothiazide in acute decompensated heart failure: A post‐hoc analysis of the CLOROTIC trial

European Journal of Heart Failure, EarlyView.
The study population included 220 participants with acute decompensated heart failure (ADHF) stratified by diuretic resistance (DR) risk using the BAN‐ADHF score. (A) Mean weight change (± standard error) at 72 h, and (B) mean change in area under the curve (AUC) of the dyspnoea visual analogue scale (VAS) at 72 h (± standard error), with higher values
Ambarish Pandey, Matthew W. Segar, Neil Keshvani, Pau Llácer, Jesús Casado, José Luis Morales‐Rull, Francesc Formiga, Luis Manzano, Harriette G.C. Van Spall, Joan Carles Trullàs   +9 more
wiley   +1 more source

Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization. [PDF]

ESC Heart Fail, 2022
Imaeda S, Shiraishi Y, Kohsaka S, Niimi N, Goda A, Nagatomo Y, Takei M, Saji M, Nakano S, Kohno T, Fukuda K, Yoshikawa T.   +11 more
europepmc   +1 more source

Real‐life implementation of guideline‐recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE‐HF

European Journal of Heart Failure, EarlyView.
Primary results of TITRATE‐HF. GRMT, guideline‐recommended medical therapy; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; LVEF, left ventricular ejection fraction. Abstract Aims Guideline‐recommended medical therapy (GRMT) improves outcomes in heart failure (HF) with reduced ejection fraction (HFrEF), yet implementation ...
Jishnu Malgie, Mariëlle I. Wilde, Stefan Koudstaal, Robert Denham, Carlos A. da Fonseca, Henk P. Swart, Clara E.E. van Ofwegen, Ayten Yilmaz, Ron Pisters, Gerard C.M. Linssen, Nikola Faber, Loek van Heerebeek, Julio E.C. van de Swaluw, Rudolf A. de Boer, Hans‐Peter Brunner‐La Rocca, Jasper J. Brugts   +15 more
wiley   +1 more source

Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: The VELOCITY study

European Journal of Heart Failure, EarlyView.
Stephen J. Greene, Stefano Corda, Ciaran J. McMullan, Giovanni Palombo, Christina Schooss, Vanja Vlajnic, Katrin Walkamp, Michele Senni, on behalf of the VELOCITY investigators   +8 more
wiley   +1 more source

Low‐dose digoxin improves cardiac function in patients with heart failure, preserved ejection fraction and atrial fibrillation – the RATE‐AF randomized trial

European Journal of Heart Failure, EarlyView.
Summary of the change in left ventricular systolic and diastolic parameters from baseline to 12 months in patients with permanent atrial fibrillation (AF) and a left ventricular ejection fraction (LVEF) ≥50%. P‐values indicate the significance of the adjusted mean difference of the parameters at 12 months between the beta‐blocker and digoxin arm. E/e′,
Karina V. Bunting, Asgher Champsi, Simrat K. Gill, Khalil Saadeh, A. John Camm, Mary Stanbury, Sandra Haynes, Jonathon N. Townend, Richard P. Steeds, Dipak Kotecha, on behalf of the RAte control Therapy Evaluation in Permanent Atrial Fibrillation (RATE‐AF) Trial Group   +10 more
wiley   +1 more source

Clinical Pharmacology of Loop Diuretics in Critical Care. [PDF]

Clin Pharmacokinet
Ferrari F, Zanza C, Tesauro M, Longhitano Y, Planinsic R, Voza A, Fumagalli J, Scaravilli V, Grasselli G.   +8 more
europepmc   +1 more source

Loop Diuretics Are Associated with Increased Risk of Hospital-Acquired Acute Kidney Injury in Adult Patients: A Retrospective Study. [PDF]

J Clin Med, 2022
Zhou L, Li Y, Gao Q, Lin Y, Su L, Chen R, Cao Y, Xu R, Luo F, Gao P, Zhang X, Li P, Nie S, Tang Y, Xu X, On Behalf Of The Each Study Investigators.   +15 more
europepmc   +1 more source

Ferric derisomaltose augments intrinsic skeletal muscle electron transport chain activity in heart failure: A FERRIC‐HF II molecular substudy

European Journal of Heart Failure, EarlyView.
FERRIC‐HF II molecular substudy. FDI, ferric derisomaltose. Aims Skeletal muscle energetic augmentation might be a mechanism via which intravenous iron improves symptoms in heart failure, but no direct measurement of intrinsic mitochondrial function has been performed to support this notion.
Mohamad F. Barakat, Nelson Amaral, Daniel Brayson, George Amin‐Youssef, Huda Abu‐Own, Salma Ayis, Francesco Papalia, Fadi Jouhra, Adam Nabeebaccus, Mark Monaghan, Gerry Carr‐White, Alison Sleigh, Geoffrey Charles‐Edwards, Ajay M. Shah, Graham J. Kemp, Andrew J. Murray, Darlington O. Okonko   +16 more
wiley   +1 more source

Loop diuretics in anuric hemodialysis patients for the clearance of protein-bound uremic toxins. [PDF]

Clin Kidney J
Sánchez-Ospina D, Romero-Cote M, Criado-Bellido L, Saez-Calero MI, Hijazi-Prieto B, Delgado-Cuesta S, Herrera-Gómez F, Mujika-Marticorena M, Gonzalez-Parra E, Izquierdo-Ortiz MJ, Mas-Fontao S.   +10 more
europepmc   +1 more source